Orion has executed several Easyhaler® products and clinical development programs in the fields of asthma and COPD:
Salbutamol: 100 and 200 µg/dose
Beclometasone: 100, 200 and 400 µg/dose
Budesonide: 100, 200, 400 µg/dose
Formoterol: 12 µg/dose
Budesonide/formoterol: 80/4.5, 160/4.5, 320/9 µg/dose
Salmeterol/fluticasone: 50/250, 50/500 µg/dose
Tiotropium (in development)
Indacaterol/glycopyrronium (in development)